Southerners living in U.S. cancer belt; Vanderbilt-Ingram Cancer Center researchers study causes of malignancy
Jul. 21, 2008—The South is known for many things: hot, steamy summers, iced tea laced with sugar and friendly people with a tendency to welcome strangers. But beneath the veneer of Southern hospitality and gracious living lurks a silent killer: cancer. Vanderbilt-Ingram Cancer Center researchers have their own name for the southern region of the United States: the "cancer belt."
Jun. 16, 2008—President George W. Bush has appointed Jennifer A. Pietenpol, director of Vanderbilt-Ingram Cancer Center, to the National Cancer Advisory Board. Pietenpol, the B.F. Byrd Jr. Professor of Oncology at Vanderbilt-Ingram, will serve a six-year term through March 9, 2014.
Mar. 13, 2008—Vanderbilt-Ingram Cancer Center has been selected as a Blue Distinction Center for Complex and Rare CancersSM by Blue Cross Blue Shield Association, in collaboration with BlueCross BlueShield of Tennessee.
Mar. 13, 2008—Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far more likely to suffer severe allergic reactions than patients in other regions of the country.
Jan. 17, 2008—Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center.
New review clears silicone gel breast implants of serious health risks; Vanderbilt-Ingram Cancer Center researchers find no cancer link
Oct. 25, 2007—Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants.
Prostate cancer patients may be eligible for less invasive therapy; Vanderbilt-Ingram Cancer Center first in state to test new ultrasound procedure
Aug. 29, 2007—Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision.
Mar. 21, 2007—As many as 30 percent of chemotherapy patients suffer from chemo fog causing moderate cognitive brain impairment. With funding help from athlete and cancer survivor Lance Armstrong, Vanderbilt University Medical Center researchers are studying how to clear chemo fog. Barb Cramer has the story.
Vanderbilt-Ingram Cancer Center, AstraZeneca Form Master Agreement to Streamline Research Collaborations
Nov. 28, 2006— The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today.
Sep. 14, 2006—Earlier this year, with surprisingly little media attention, we celebrated a major milestone in the fight against cancer — for the first time in record-keeping history, the number of American lives lost to cancer declined.
Aug. 24, 2006—The Vanderbilt Breast Center is offering a new class for breast cancer survivors during or after treatment, using the ancient Chinese practice of Qigong, pronounced "chee gung," to help promote renewal and restoration.
First Adult Cancer Patient in Nashville to Receive Stem Cell Transplant from Umbilical Cord Blood at Vanderbilt-Ingram Cancer Center
Jun. 8, 2006—When 24-year-old Charles Dougherty checks into Vanderbilt-Ingram Cancer Center tomorrow, he'll be preparing for a treatment that has never been performed before in an adult patient in Nashville, and will be only the second case in Tennessee history.